Gilead's Trodelvy Ignites Hope & Stock Frenzy with 38% Breast Cancer Breakthrough!

Beyond COVID: mRNA Vaccines Unleash a New Weapon Against Cancer's Toughest Foes

A New Dawn for Breast Cancer Treatment: Roche's Gedatolisib and Giredestrant Combination Shows Promise

FDA Unleashes Game-Changing Incentive: Priority Review Vouchers Set to Revolutionize Drug Development

Unraveling Nature's Knots: How AI is Revolutionizing the Discovery of Lasso Peptides

The Revolving Door: Ex-FDA Regulators Find New Homes at Pharma Giants Like Eli Lilly

Biotech's Vanguard: Novo Nordisk, Omeros, and GSK Charting New Territories in Medical Innovation

Cidara Therapeutics Skyrockets as Morgan Stanley Elevates Rating to 'Overweight'

FDA Pumps the Brakes: Denali Therapeutics' Hunter Syndrome Drug Faces Extended Review

BioCryst Pharmaceuticals Strikes Strategic $700 Million Deal, Propelling Astria's HAE Pipeline and Strengthening Its Own Focus

Under Siege: Whistleblowers Unmask Political Pressures Threatening FDA's Scientific Soul

Revolutionizing Biopharma: Waters Unveils Breakthrough Charge Detection Mass Spectrometry for Next-Gen Therapies

Unlocking Tomorrow's Cures: Bristol Myers Squibb's Daring Dive into Next-Gen Autoimmune Cell Therapies

Boston-Cambridge: The Unrivaled Epicenter of Global Biotech Innovation

Monopar's Breakthrough in Wilson Disease: A New Dawn with AstraZeneca's Shadow

Unlocking Cures: The Pharmaceutical Industry's Toughest Battle in the Global South

A New Chapter: Peter Marks, Former FDA Vaccine Czar, Lands at Eli Lilly

A Billion-Dollar Bet: Eli Lilly's Monumental Investment Ignites India's Pharma Future

Lyra Therapeutics Gambles on Higher Dose in New Phase 3 Trial Following Previous Setback for Chronic Rhinosinusitis Treatment

Cagrisema: Novo Nordisk's Dual-Action Powerhouse Poised to Revolutionize Obesity Treatment

A New Horizon in Breast Cancer Treatment: AstraZeneca's Datroway Extends Lives and Boosts Hopes

Telangana's Trillion-Dollar Leap: Eli Lilly Injects $1 Billion, Reshaping India's Pharma Future

Europe's Bold New Pharma Gambit: A High-Stakes Bet on Access Over Profit?

The Perilous Bargain: Are We Trading Future Cures for Today's Drug Savings?

The Future of Fat Loss: Novo Nordisk Unleashes Its Next-Gen Weapon in the High-Stakes Drug Wars

The Epic Saga of Ozempic: From a 1970s Experiment to a Modern Medical Marvel

A New Dawn for Science: NIH Spearheads the Revolution in Humane Research

India's Imperative: Seizing the AI Revolution in Drug Discovery

Biotech's Q4 Reckoning: Navigating the Storm, Charting the Future

Unveiling the Maternal Research Gap: Why Pregnant Women Need to Be Included in Clinical Trials

Trump's Landmark Drug Price Promise: A Deadline Vanished, Unnoticed

Anavex Life Sciences Unveils Landmark Publication: Blarcamesine Heralds a New Era in Neurological Treatment

UC Irvine's Dr. Cellek Secures Major Grant to Revolutionize Cancer Treatment with Safer Therapies

AnaptysBio Unleashes Dual Powerhouse: Splitting into Dedicated Immunology and Oncology Ventures

Enanta's Enigma: Stock Soars as RSV Drug Misses Primary Goal, Finds Hope in Secondary Wins

Acoramidis: A Beacon of Hope for Rare Heart Disease Patients with Rapid Cardiac Benefit

Game-Changing Partnership: Hanmi Pharmaceutical's Oral Delivery Platform Licensed to Gilead Sciences

Biotech Blockbuster Alert: Genmab Edges Closer to Game-Changing Merus Acquisition

Unlocking the Future of Medicine: How a Revolutionary Protein Could Redefine Drug Delivery and Safety